Regina Dugan, CEO of new biomedical non-profit Wellcome Leap and former director of the Defense Advanced Research Projects Agency (DARPA) in the U.S., joins Azeem Azhar to explore how she approaches delivering breakthrough technologies, and why she has now set her sights on global health.

They also discuss:

• The thinking behind DARPA’s early support of Moderna’s mRNA vaccine technology.

• How the DARPA model of innovation can apply to advancing medical technologies.

• How the lessons from her experience of childhood cancer have guided Dugan’s career.

Finish.Company favorite: from min. 16.10: Darpa operates a 3.5B$ budget, with 250 people, this provides maximum flexibility to hire external talent where and when the mission requires. This type of agility enables the company to achieve missions that others rate as impossible.

Click HERE to listen to the podcast.

@azeem
@ExponentialView
@WellcomeLeap

@FinishCompany 

Leave a Reply

Your email address will not be published.

%d bloggers like this: